ATE57526T1 - P-acylaminobenzamide. - Google Patents

P-acylaminobenzamide.

Info

Publication number
ATE57526T1
ATE57526T1 AT86306598T AT86306598T ATE57526T1 AT E57526 T1 ATE57526 T1 AT E57526T1 AT 86306598 T AT86306598 T AT 86306598T AT 86306598 T AT86306598 T AT 86306598T AT E57526 T1 ATE57526 T1 AT E57526T1
Authority
AT
Austria
Prior art keywords
acylaminobenzamide
acylamino
pharmaceutical formulations
provides certain
benzamide derivatives
Prior art date
Application number
AT86306598T
Other languages
English (en)
Inventor
David Wayne Robertson
Edward Earl Beedle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE57526T1 publication Critical patent/ATE57526T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT86306598T 1985-08-30 1986-08-27 P-acylaminobenzamide. ATE57526T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/771,455 US4642379A (en) 1985-08-30 1985-08-30 Intermediates for anticonvulsant agents
EP86306598A EP0213924B1 (de) 1985-08-30 1986-08-27 p-Acylaminobenzamide

Publications (1)

Publication Number Publication Date
ATE57526T1 true ATE57526T1 (de) 1990-11-15

Family

ID=25091883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86306598T ATE57526T1 (de) 1985-08-30 1986-08-27 P-acylaminobenzamide.

Country Status (17)

Country Link
US (1) US4642379A (de)
EP (1) EP0213924B1 (de)
JP (1) JPS6259249A (de)
KR (1) KR900000275B1 (de)
CN (1) CN1010680B (de)
AT (1) ATE57526T1 (de)
AU (1) AU580890B2 (de)
DE (1) DE3674971D1 (de)
DK (1) DK412286A (de)
ES (1) ES2001411A6 (de)
HU (1) HU197029B (de)
IL (1) IL79835A0 (de)
NZ (1) NZ217356A (de)
PH (1) PH23173A (de)
PT (1) PT83253B (de)
SU (1) SU1486055A3 (de)
ZA (1) ZA866429B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
US4939163A (en) * 1987-02-18 1990-07-03 Eli Lilly And Company Anticonvulsant agents
US4835181A (en) * 1987-02-18 1989-05-30 Eli Lilly And Company Anticonvulsant agents using cyano dimethylphenyl benzamides
US4981866A (en) * 1987-02-18 1991-01-01 Eli Lilly And Company Anticonvulsant agents
AU710071B2 (en) * 1996-05-14 1999-09-16 Bristol-Myers Squibb Company Anticonvulsant pyridinyl benzamide derivatives
KR20100039429A (ko) * 2007-08-02 2010-04-15 에프. 호프만-라 로슈 아게 Ｃｎｓ 질환의 치료를 위한 벤즈아미드 유도체의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2224153B1 (de) * 1973-04-04 1977-11-10 Upjohn Co
US4004029A (en) * 1974-05-13 1977-01-18 The Upjohn Company Compositions and method for treating epilepsy and convulsions
US4379165A (en) * 1981-05-18 1983-04-05 Research Corporation Anti-convulsant
US4629740A (en) * 1984-04-10 1986-12-16 Eli Lilly And Company Anticonvulsant agents
US4835181A (en) * 1987-02-18 1989-05-30 Eli Lilly And Company Anticonvulsant agents using cyano dimethylphenyl benzamides

Also Published As

Publication number Publication date
PT83253B (pt) 1989-03-30
ES2001411A6 (es) 1988-05-16
ZA866429B (en) 1988-04-27
CN1010680B (zh) 1990-12-05
US4642379A (en) 1987-02-10
EP0213924A3 (en) 1987-09-30
EP0213924A2 (de) 1987-03-11
AU6206486A (en) 1987-03-05
HU197029B (en) 1989-02-28
CN86105906A (zh) 1987-02-25
PH23173A (en) 1989-05-19
NZ217356A (en) 1989-05-29
KR870002053A (ko) 1987-03-28
DE3674971D1 (en) 1990-11-22
AU580890B2 (en) 1989-02-02
EP0213924B1 (de) 1990-10-17
DK412286D0 (da) 1986-08-29
SU1486055A3 (ru) 1989-06-07
PT83253A (en) 1986-09-01
DK412286A (da) 1987-03-01
HUT41817A (en) 1987-05-28
KR900000275B1 (ko) 1990-01-24
IL79835A0 (en) 1986-11-30
JPS6259249A (ja) 1987-03-14

Similar Documents

Publication Publication Date Title
ATE231872T1 (de) Thiazolopyrimidinderivate
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ATE28188T1 (de) Antikonvulsive mittel.
ATE75583T1 (de) Nicarbazin enthaltende vormischungszusammensetzungen.
ATE57526T1 (de) P-acylaminobenzamide.
ATE87905T1 (de) Anticonvulsive agenzien.
NO985079L (no) Eksplosiv formulering
MX9203103A (es) Androsta-1-,4-dien-3,17-dionas substituidas y composiciones farmaceuticas que las contienen.
GR1001368B (el) Φαρμακευτικοί φορείς.
MX9203261A (es) Nuevas 12-amino-piridazino [4',5':3,4] pirrolo[2,1-a]-isoquinolinas y composiciones farmaceuticas que las contienen.
MX9203485A (es) Derivados de tieno sulfonamida, composiciones farmaceuticas y uso.
IT8322815A0 (it) Formulazioni farmaceutiche adattivita' antisettica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee